Published in
Springer, Investigational New Drugs, 6(30), p. 2303-2317, 2011
DOI: 10.1007/s10637-011-9766-6
Links
Tools
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
Journal article published in 2011 by
Michael J. Millward,
Timothy Price 
,
Amanda Townsend,
Christopher Sweeney,
Andrew Spencer,
Shawgi Sukumaran,
Angie Longenecker,
Lonnie Lee,
Ana Lay,
Girish Sharma,
Robert M. Gemmill,
Harry A. Drabkin,
G. Kenneth Lloyd,
Saskia T. C. Neuteboom,
David J. McConkey
and other authors.
,
Amanda Townsend,
Christopher Sweeney,
Andrew Spencer,
Shawgi Sukumaran,
Angie Longenecker,
Lonnie Lee,
Ana Lay,
Girish Sharma,
Robert M. Gemmill,
Harry A. Drabkin,
G. Kenneth Lloyd,
Saskia T. C. Neuteboom,
David J. McConkey
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 